Published in Int Immunol on November 08, 2010
Targeting pathological B cell receptor signalling in lymphoid malignancies. Nat Rev Drug Discov (2013) 2.31
Pathogenesis of follicular lymphoma. J Clin Invest (2012) 1.66
Lectins from opportunistic bacteria interact with acquired variable-region glycans of surface immunoglobulin in follicular lymphoma. Blood (2015) 1.53
B-cell receptor signaling as a driver of lymphoma development and evolution. Semin Cancer Biol (2013) 1.39
Automated analysis of high-throughput B-cell sequencing data reveals a high frequency of novel immunoglobulin V gene segment alleles. Proc Natl Acad Sci U S A (2015) 1.28
DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma. Blood (2015) 1.15
Automated cleaning and pre-processing of immunoglobulin gene sequences from high-throughput sequencing. Front Immunol (2012) 0.96
Self-antigen recognition by follicular lymphoma B-cell receptors. Blood (2012) 0.95
Integrating B cell lineage information into statistical tests for detecting selection in Ig sequences. J Immunol (2013) 0.93
Somatic hypermutation analysis in follicular lymphoma provides evidence suggesting bidirectional cell migration between lymph node and bone marrow during disease progression and relapse. Haematologica (2013) 0.86
Automated analysis of immunoglobulin genes from high-throughput sequencing: life without a template. J Clin Bioinforma (2013) 0.83
Immunoglobulin gene repertoire diversification and selection in the stomach - from gastritis to gastric lymphomas. Front Immunol (2014) 0.82
Old questions, new tools: does next-generation sequencing hold the key to unraveling intestinal B-cell responses? Mucosal Immunol (2014) 0.77
Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med (2010) 67.34
Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem (2002) 4.24
Common variable immunodeficiency: a new look at an old disease. Lancet (2008) 2.75
Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice. Clin Chem (2005) 2.64
Diabetes blockade of sevoflurane postconditioning is not restored by insulin in the rat heart: phosphorylated signal transducer and activator of transcription 3- and phosphatidylinositol 3-kinase-mediated inhibition. Anesthesiology (2011) 2.29
DNA vaccines: precision tools for activating effective immunity against cancer. Nat Rev Cancer (2008) 2.23
Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma. Blood (2002) 2.01
Rituximab therapy in idiopathic membranous nephropathy: a 2-year study. Clin J Am Soc Nephrol (2010) 1.89
A-to-I RNA editing occurs at over a hundred million genomic sites, located in a majority of human genes. Genome Res (2013) 1.81
Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules. J Exp Med (2005) 1.76
Bystander stimulation of activated CD4+ T cells of unrelated specificity following a booster vaccination with tetanus toxoid. Eur J Immunol (2010) 1.65
Primary central nervous system lymphoma: tumor-related clones exist in the blood and bone marrow with evidence for separate development. Blood (2008) 1.63
IgTree: creating Immunoglobulin variable region gene lineage trees. J Immunol Methods (2008) 1.58
Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status. Blood (2007) 1.55
DNA vaccination induces WT1-specific T-cell responses with potential clinical relevance. Blood (2008) 1.51
Mantle cell lymphoma with t(11;14) and unmutated or mutated VH genes expresses AID and undergoes isotype switch events. Blood (2003) 1.49
Correlation of serum immunoglobulin free light chain quantification with urinary Bence Jones protein in light chain myeloma. Clin Chem (2002) 1.49
Patients aged 80 and older undergoing orthopedic or urologic surgery: a prospective study focusing on perioperative morbidity and mortality. Gerontology (2009) 1.44
Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays. Mayo Clin Proc (2006) 1.43
Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia. Immunology (2005) 1.41
Clinical efficacy of gene-modified stem cells in adenosine deaminase-deficient immunodeficiency. J Clin Invest (2017) 1.39
Immunoglobulin heavy chain locus events and expression of activation-induced cytidine deaminase in epithelial breast cancer cell lines. Cancer Res (2006) 1.39
DNA vaccination with electroporation induces increased antibody responses in patients with prostate cancer. Hum Gene Ther (2009) 1.34
Vaccination of human subjects expands both specific and bystander memory T cells but antibody production remains vaccine specific. Blood (2005) 1.23
Association of an increased frequency of CD14+ HLA-DR lo/neg monocytes with decreased time to progression in chronic lymphocytic leukaemia (CLL). Br J Haematol (2011) 1.21
Human follicular lymphoma cells contain oligomannose glycans in the antigen-binding site of the B-cell receptor. J Biol Chem (2006) 1.19
Mechanisms of immunosenescence. Immun Ageing (2009) 1.19
Electroporation as a "prime/boost" strategy for naked DNA vaccination against a tumor antigen. J Immunol (2005) 1.18
The normal IGHV1-69-derived B-cell repertoire contains stereotypic patterns characteristic of unmutated CLL. Blood (2009) 1.15
Classification of human natural killer cells based on migration behavior and cytotoxic response. Blood (2013) 1.15
Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins. Proc Natl Acad Sci U S A (2010) 1.14
Age- and tissue-specific differences in human germinal center B cell selection revealed by analysis of IgVH gene hypermutation and lineage trees. Eur J Immunol (2002) 1.14
Evidence for large diversity in the human transcriptome created by Alu RNA editing. Nucleic Acids Res (2009) 1.12
Surface IgM stimulation induces MEK1/2-dependent MYC expression in chronic lymphocytic leukemia cells. Blood (2011) 1.11
The ageing B cell population: composition and function. Biogerontology (2009) 1.11
Evidence for involvement of a hydrophobic patch in framework region 1 of human V4-34-encoded Igs in recognition of the red blood cell I antigen. J Immunol (2002) 1.11
Mechanisms and clinical significance of BIM phosphorylation in chronic lymphocytic leukemia. Blood (2011) 1.09
Identification in CLL of circulating intraclonal subgroups with varying B-cell receptor expression and function. Blood (2013) 1.05
Harmonization of the intracellular cytokine staining assay. Cancer Immunol Immunother (2012) 1.05
Fit for purpose? A case study: validation of immunological endpoint assays for the detection of cellular and humoral responses to anti-tumour DNA fusion vaccines. Cancer Immunol Immunother (2008) 1.03
Deregulated expression of the Myc cellular oncogene drives development of mouse "Burkitt-like" lymphomas from naive B cells. Blood (2004) 1.02
Models for antigen receptor gene rearrangement: CDR3 length. Immunol Cell Biol (2007) 1.01
Immunotherapy of hematologic malignancy. Hematology Am Soc Hematol Educ Program (2003) 1.00
DNA vaccines against cancer come of age. Curr Opin Immunol (2010) 0.99
Epidemiology of infections requiring hospitalization during long-term follow-up of pancreas transplantation. Transplantation (2010) 0.99
DNA vaccines to attack cancer. Proc Natl Acad Sci U S A (2004) 0.98
Typical Waldenstrom macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch events. Blood (2002) 0.98
The dynamics of germinal centre selection as measured by graph-theoretical analysis of mutational lineage trees. Dev Immunol (2002) 0.97
Autoimmune cytopenias in common variable immunodeficiency. Front Immunol (2012) 0.97
Designing an A* algorithm for calculating edit distance between rooted-unordered trees. J Comput Biol (2006) 0.97
Common patterns of B cell perturbation and expanded V4-34 immunoglobulin gene usage in autoimmunity and infection. Autoimmunity (2004) 0.97
Automated cleaning and pre-processing of immunoglobulin gene sequences from high-throughput sequencing. Front Immunol (2012) 0.96
Public T cell receptor beta-chains are not advantaged during positive selection. J Immunol (2008) 0.96
Natural killer cell tolerance persists despite significant reduction of self MHC class I on normal target cells in mice. PLoS One (2010) 0.96
Somatic hypermutation and antigen-driven selection of B cells are altered in autoimmune diseases. J Autoimmun (2010) 0.96
Features of the overexpressed V1-69 genes in the unmutated subset of chronic lymphocytic leukemia are distinct from those in the healthy elderly repertoire. Blood (2002) 0.95
Ectopic GC in the thymus of myasthenia gravis patients show characteristics of normal GC. Eur J Immunol (2010) 0.95
Probing natural killer cell education by Ly49 receptor expression analysis and computational modelling in single MHC class I mice. PLoS One (2009) 0.93
DNA fusion gene vaccines against cancer: from the laboratory to the clinic. Immunol Rev (2004) 0.93
Critical components of a DNA fusion vaccine able to induce protective cytotoxic T cells against a single epitope of a tumor antigen. J Immunol (2002) 0.93
Adult-onset manifestation of idiopathic T-cell lymphopenia due to a heterozygous RAG1 mutation. J Allergy Clin Immunol (2012) 0.92
Incidence of potential glycosylation sites in immunoglobulin variable regions distinguishes between subsets of Burkitt's lymphoma and mucosa-associated lymphoid tissue lymphoma. Br J Haematol (2003) 0.92
Antigen-driven selection in germinal centers as reflected by the shape characteristics of immunoglobulin gene lineage trees: a large-scale simulation study. J Theor Biol (2008) 0.92
Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment. Health Qual Life Outcomes (2012) 0.92
Surface IgM of CLL cells displays unusual glycans indicative of engagement of antigen in vivo. Blood (2010) 0.91
Hairy cell leukemia: at the crossroad of somatic mutation and isotype switch. Blood (2004) 0.91
Posterior reversible encephalopathy syndrome after combined general and spinal anesthesia with intrathecal morphine. Anesth Analg (2009) 0.90
B cell development in aging mice: lessons from mathematical modeling. Int Immunol (2005) 0.90
A gamma-herpesvirus immune evasion gene allows tumor cells in vivo to escape attack by cytotoxic T cells specific for a tumor epitope. Eur J Immunol (2002) 0.90
Prime-boost with alternating DNA vaccines designed to engage different antigen presentation pathways generates high frequencies of peptide-specific CD8+ T cells. J Immunol (2006) 0.90
Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency. J Clin Invest (2015) 0.90
Remarkable selective glycosylation of the immunoglobulin variable region in follicular lymphoma. Mol Immunol (2007) 0.90
Tapasin shapes immunodominance hierarchies according to the kinetic stability of peptide-MHC class I complexes. Eur J Immunol (2008) 0.89
Patterns of somatic mutations in VH genes reveal pathways of clonal transformation from MGUS to multiple myeloma. Blood (2003) 0.88
B-cell clonal diversification and gut-lymph node trafficking in ulcerative colitis revealed using lineage tree analysis. Eur J Immunol (2008) 0.87
Lineage tree analysis of immunoglobulin variable-region gene mutations in autoimmune diseases: chronic activation, normal selection. Cell Immunol (2007) 0.86